UK Newborn Screening Market Size & Outlook, 2025-2033

The newborn screening market in UK is expected to reach a projected revenue of US$ 71.3 million by 2033. A compound annual growth rate of 7.8% is expected of UK newborn screening market from 2025 to 2033.
Revenue, 2024 (US$M)
$36.7
Forecast, 2033 (US$M)
$71.3
CAGR, 2025 - 2033
7.8%
Report Coverage
UK

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK newborn screening market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK newborn screening market highlights

  • The UK newborn screening market generated a revenue of USD 36.7 million in 2024 and is expected to reach USD 71.3 million by 2033.
  • The UK market is expected to grow at a CAGR of 7.8% from 2025 to 2033.
  • In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2024.
  • Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.


Newborn screening market data book summary

Market revenue in 2024USD 36.7 million
Market revenue in 2033USD 71.3 million
Growth rate7.8% (CAGR from 2025 to 2033)
Largest segmentTandem mass spectrometry
Fastest growing segmentElectrophoresis
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis
Key market players worldwideBio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp


Other key industry trends

  • In terms of revenue, UK accounted for 4.1% of the global newborn screening market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, UK newborn screening market is projected to lead the regional market in terms of revenue in 2033.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 50.8 million by 2033.

Tandem mass spectrometry was the largest segment with a revenue share of 26.43% in 2024. Horizon Databook has segmented the UK newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2021 to 2033.


The UK National Screening Committee (UK NSC) has been set up to carry out testing over these neonates for evidences of any congenital anomalies. All states of UK uniformly screen for five mandated disorders.

However, Northern Ireland screens for seven anomalies. In May 2014, four new conditions were added that included Isovaleric (IVA), Homocystinuria (HCU), Glutaric Type 1 (GA1), and Maple Syrup Urine Disease (MSUD). Approval for adding these was done post-completion of the pilot study, which was funded by National Institute for Health Research.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Newborn Screening Market Companies

Name Profile # Employees HQ Website
Covidien View profile 10001+ Dublin, Dublin, Ireland, Europe http://www.covidien.com
Natus Medical View profile 1001-5000 San Carlos, California, United States, North America http://www.natus.com
Agilent Technologies View profile 10001+ Santa Clara, California, United States, North America http://www.agilent.com
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Masimo Corp View profile 3796 52 Discovery, Irvine, CA, United States, 92618 https://www.masimo.com
Waters Corp View profile 7900 34 Maple Street, Milford, MA, United States, 01757 https://www.waters.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com

UK newborn screening market size, by technology, 2021-2033 (US$M)

UK Newborn Screening Market Outlook Share, 2024 & 2033 (US$M)

UK newborn screening market size, by technology, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online